Suppr超能文献

链脲佐菌素诱导糖尿病大鼠肾肾小球多药耐药相关蛋白 1(MRP1)表达增加。

Increased expression of the multidrug resistance-associated protein 1 (MRP1) in kidney glomeruli of streptozotocin-induced diabetic rats.

机构信息

Instituto de Bioquímica, Facultad de Ciencias, Universidad Austral de Chile, Valdivia, Chile.

出版信息

Biol Chem. 2011 Apr;392(6):529-37. doi: 10.1515/BC.2011.052. Epub 2011 Apr 17.

Abstract

Oxidative stress has been linked to the podocytopathy, mesangial expansion and progression of diabetic nephropathy. The major cell defence mechanism against oxidative stress is reduced glutathione (GSH). Some ABC transporters have been shown to extrude GSH, oxidised glutathione or their conjugates out of the cell, thus implying a role for these transporters in GSH homeostasis. We found a remarkable expression of mRNA for multidrug resistance-associated proteins (MRP/ABCC) 1, 3, 4 and 5 in rat glomeruli. Three weeks after induction of diabetes in glomeruli of streptozotocin-treated rats, we observed a decline in reduced GSH levels and an increase in the expression and activity of MRP1 (ABCC1). These lower GSH levels were improved by ex vivo treatment with pharmacological inhibitors of MRP1 activity (MK571). We conclude that increased activity of MRP1 in diabetic glomeruli is correlated with an inadequate adaptive response to oxidative stress.

摘要

氧化应激与足细胞病变、系膜扩张和糖尿病肾病的进展有关。细胞对抗氧化应激的主要防御机制是还原型谷胱甘肽(GSH)。一些 ABC 转运蛋白已被证明可将 GSH、氧化型谷胱甘肽或其共轭物从细胞内排出,这意味着这些转运蛋白在 GSH 稳态中发挥作用。我们发现大鼠肾小球中多药耐药相关蛋白 (MRP/ABCC) 1、3、4 和 5 的 mRNA 表达显著。在链脲佐菌素处理的大鼠肾小球诱导糖尿病 3 周后,我们观察到还原型 GSH 水平降低,MRP1(ABCC1)的表达和活性增加。MRP1 活性的药理学抑制剂 (MK571) 的离体处理改善了这些较低的 GSH 水平。我们的结论是,糖尿病肾小球中 MRP1 活性的增加与对氧化应激的适应性反应不足有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验